Clinical Trial

Multicenter Study on Postoperative Urinary and Sexual Function During Laparoscopic Functional Total Mesorectum Excision

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 1, 2021 (before its estimated September 24, 2022 completion). Its status may not reflect the trial's current state.
Summary
Urinary and sexual dysfunctions are among the most common complications in rectal cancer surgery. The aim of this study was to investigate the protective effect of laparoscopic functional total mesorectum excision (FTME) on urinary and sexual function in male patients with mid-low rectal cancer. This is a prospective, single-arm, multicenter, uncontrolled, clinical study in 88 eligible subjects with mid-low rectal cancer. After informed consent, eligible patients will be performed laparoscopic FTME surgery. Patients' demographic, operative detail, postoperative outcomes and follow-up will be recorded prospectively.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2021-09-10.
Trial Details
NCT Number NCT05049317
Lead Sponsor Renmin Hospital of Wuhan University
Conditions Rectal Cancer
Enrollment 88 participants
Start Date 2021-11-24
Primary Completion 2022-09-24 (estimated)
Study Completion 2028-09-24 (estimated)
Updated on ClinicalTrials.gov 2021-11-01